97 related articles for article (PubMed ID: 2506557)
1. Interferon-gamma in the treatment of superficial and recurrent bladder carcinoma. Phase one study.
Fontana G; Caccia P; Alladio F; Laudi M; Pigato M; Sesia G; Forni G; Giovarelli M
Prog Clin Biol Res; 1989; 303():479-80. PubMed ID: 2506557
[No Abstract] [Full Text] [Related]
2. The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.
Vögeli TA
BJU Int; 2005 Dec; 96(8):1171-6. PubMed ID: 16285875
[No Abstract] [Full Text] [Related]
3. [Biological response modifiers and their use in urology: our experience].
Fontana G; Bozzo R; Sesia G; Cavallo GP; Forni G
G Batteriol Virol Immunol; 1989; 82(1-12):39-47. PubMed ID: 2518762
[No Abstract] [Full Text] [Related]
4. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma.
Colombo R; Da Pozzo LF; Salonia A; Rigatti P; Leib Z; Baniel J; Caldarera E; Pavone-Macaluso M
J Clin Oncol; 2003 Dec; 21(23):4270-6. PubMed ID: 14581436
[TBL] [Abstract][Full Text] [Related]
5. Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2.
Grasso M; Torelli F; Scannapieco G; Franzoso F; Lania C
J Immunother; 2001; 24(2):184-7. PubMed ID: 11265776
[TBL] [Abstract][Full Text] [Related]
6. [Superficial bladder carcinoma -- trend of less aggressive therapies].
Friedrich MG
Aktuelle Urol; 2006 Jul; 37(4):254-6. PubMed ID: 16955957
[No Abstract] [Full Text] [Related]
7. The management of superficial bladder cancer.
Soloway MS
Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
[No Abstract] [Full Text] [Related]
8. [Intravesical chemotherapy with interferon in superficial bladder tumors].
Tanahashi T; Matsumura Y; Yoshimoto J; Tsushima T; Obama T; Akagi T; Ochi J; Hara M; Saegusa M; Ohmori H
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1156-9. PubMed ID: 3105469
[TBL] [Abstract][Full Text] [Related]
9. [Chemo-immunoprevention in superficial bladder cancer].
Adolphs HD; Bastian HP
Urologe A; 1986 Jan; 25(1):51-4. PubMed ID: 3962045
[TBL] [Abstract][Full Text] [Related]
10. [Results and long-term course of superficial bladder carcinomas treated with local adriamycin. Apropos of 69 cases].
Iborra I; Mazcuñán F; Monros JL; Ricos JV; Solsona E
Arch Esp Urol; 1987 Sep; 40(7):455-60. PubMed ID: 3688987
[No Abstract] [Full Text] [Related]
11. [Four cases of upper urinary tract transitional cell carcinoma after radical cystectomy in bladder cancer].
Nishio Y; Kaku S; Hida S; Ohishi K; Okada Y; Yoshida O
Hinyokika Kiyo; 1988 Sep; 34(9):1593-9. PubMed ID: 3213794
[TBL] [Abstract][Full Text] [Related]
12. Intravesical therapy for superficial bladder cancer: slow but steady progress.
Lamm DL
J Clin Oncol; 2003 Dec; 21(23):4259-60. PubMed ID: 14581444
[No Abstract] [Full Text] [Related]
13. [Comparative study of treatments of bladder carcinoma: TUR, thiotepa or BCG].
Rodrigues Netto Júnior N; Caserta Lemos G
Arch Esp Urol; 1981; 34(5):369-74. PubMed ID: 6800309
[No Abstract] [Full Text] [Related]
14. [Testicular metastasis from transitional cell carcinoma of the bladder].
Negelev S; Paz A; Segal M
Harefuah; 1995 Jan; 128(2):90-1, 127. PubMed ID: 7721183
[TBL] [Abstract][Full Text] [Related]
15. [The urethra of the patient cystectomized for bladder carcinoma: role of total urethrectomy].
Virseda JA; Bolaño N; Melchor A; Alvarez F
Arch Esp Urol; 1987; 40(9):657-63. PubMed ID: 3326533
[No Abstract] [Full Text] [Related]
16. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
Kurth KH
Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
[No Abstract] [Full Text] [Related]
17. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
18. Evaluation criteria: a protocol to study patterns of care and their effects in patients with transitional cell carcinoma of the bladder (protocol 1).
Prout GR; Kopp J
Prog Clin Biol Res; 1984; 162A():285-99. PubMed ID: 6483913
[No Abstract] [Full Text] [Related]
19. Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.
de Reijke TM; de Boer EC; Kurth KH; Schamhart DH
J Urol; 1996 Feb; 155(2):477-82. PubMed ID: 8558640
[TBL] [Abstract][Full Text] [Related]
20. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
Pham HT; Soloway MS
Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
